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. Surface area of Eg5 interfacing with inhibitor (A), volume and molecular surface area in the pocket (B), and shape complementarity of the interface (C) of Eg5 -inhibitor complexes.
(A) The surface area of Eg5 interfacing with each inhibitor was calculated using AREAIMOL in the CCP4 suite.
The surface area of each residue interfacing with the inhibitor is shown. The residues that belong to the walls forming the binding pocket are shown in Figure 4B . The other residues, T112, G117, E118, D130, A218, and T222, are located at the corners of the pocket, so they do not belong to any components forming the walls. (B)
The volume and molecular surface area of the pocket of Eg5 interfacing with each inhibitor were calculated using
CASTp. (C) The shape complementarity of the interface between the Eg5 motor domain and each inhibitor was calculated using Sc. In the program Sc, 3 the shape correlation Sc is defined as follows: on molecular surfaces PA and PB between the interacting molecules A and B, xA is a point of PA, nA is the outwardly oriented unit vector normal to the PA surface at xA, and x′A is a point of PB nearest to xA, n′A is its inwardly oriented unit vector normal to the PB surface at x′A. The function
] is defined at every point on PA, presicely, and Sc ~ 0 will be uncorrelated in their topography. In all cases (A), (B), and (C), molecule A was used.
PVEI0138, Eg517-369 -PVEI0138 complex; PVEI0021, Eg517-369 -PVEI0021 complex (P21-type); STLC, Eg51-368 -STLC complex (PDB code 2WOG). Molecules A of the Eg5 motor domain in complex with PVEI0138, PVEI0021 (P21-type), and STLC are in similar structures with rmsd values less than 0.8 Å (Table S2) . L10 is an outstanding loop, and readily have different conformations among Eg5 structures. L10 and loop regions between 0 and 1a and between2 and 4
show relatively large deviations between the superposed structures. The difference in the loop region between 0
and 1a may be derived from differences in crystal packing.
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A Figure S3 . Plots of C-atom distances between two structures after least-squares fitting using PDBeFold 1 as described in Table S2 . In all cases, molecule A was used. Each rmsd value is also shown. As described above, in the P21-and C2-type structures, inter-molecular interactions via the L10 loops are observed from different pairs of molecules. However, given that molecules A and B are in nearly the same S11 structures, the patterns of crystal packing can be regarded as being nearly the same between the structures of the 
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Supplementary Methods
Construction of the Plasmid. The primers used in this study are listed in Supplementary Table S1 . The cDNA corresponding to the motor domain of Eg5 (coding for residues 17 to 369 of Eg5) fused to a His6 tag at the C terminus was prepared by PCR using pEg51-369 and the primer pair #1 and #2. 5 To construct an expression plasmid of the Eg5 motor domain, the amplified cDNA was inserted between the Nde I and Xba I sites of pCold III (Takara Bio Inc.) to generate pEg517-369, which expressed the Eg5 motor domain prolonged by MNHKVHM at the N-terminus and by QHHHHHH at the C-terminus. The N-terminal extra sequence comes from pCold III vector and works to induce high-yield production of recombinant proteins through enhancing translation initiation. 6, 7 The sequence of cDNA prepared by PCR was confirmed by DNA sequencing. with the same buffer, the proteins were eluted with a buffer containing 500 mM imidazole, 50 mM piperazine-1,4-bis(2-ethanesulfonic acid)(PIPES)-NaOH (pH 6.8), 0.1 M NaCl, 1 mM ADP, 2 mM MgCl2, 5 mM β-mercaptoethanol, 10% (w/v) sucrose. The eluted proteins were loaded onto a 1 mL HiTrap SP HP cation-exchange column (GE Healthcare) in an AKTAprime plus system (GE Healthcare) using a buffer containing 50 mM PIPES-NaOH (pH 6.8), 1 mM ADP, 2 mM MgCl2, 1 mM EGTA-NaOH, 1 mM tris(2-carboxyethyl)phosphine (TCEP)-HCl, and 5% (w/v) sucrose, and then eluted with a linear gradient from 0 to 1.0 M NaCl. The resultant protein was concentrated using a Vivaspin-20 centrifugal concentrator (Sartorius) with a 10 kDa molecular-mass cut-off. Samples (about 20 mg/ml) were stored at -20C until use. The concentration
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